Skip to main content

Published locations for Upadacitinib in a 15 mg dose could achieve robust efficacy in PsA with limited adverse events

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Upadacitinib in a 15 mg dose could achieve robust efficacy in PsA with limited adverse events

User login

  • Reset your password
  • /content/upadacitinib-15-mg-dose-could-achieve-robust-efficacy-psa-limited-adverse-events
  • /dermatology/article/246624/psoriasis/upadacitinib-15-mg-dose-could-achieve-robust-efficacy-psa